UiPath shares moved higher after the company joined a leading industry group focused on agent-based AI standards.

If you are wondering whether UiPath's current share price really reflects what the business is worth, you are not alone. This article will help you unpack that question. UiPath shares last closed at ...

ServiceNow and UiPath could become agentic AI leaders.

The decline came as Anthropic announced the acquisition of Vercept, a company focused on AI perception and interaction problems. Vercept’s technology enables AI systems to navigate and operate within ...

UiPath isn't down for the count, but it faces existential challenges.

UiPath (PATH) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Over the ...

Nebius and UiPath are promising AI companies, but one's fundamentals shine brighter than the other's.

​UiPath, Inc. (NYSE:PATH) is one of the Best All-Time Low Stocks to Invest In Now. On February 23, UiPath, Inc. (NYSE:PATH), ...

UiPath PATH, a key player in the robotic process automation (“RPA”) market, is trading at a forward 12-month price-to-sales (P/S) ratio of 4.12X, significantly below the industry average of 5.75X.

UiPath (NYSE:PATH) introduced new AI tools for healthcare at the ViVE 2026 conference. The offerings include medical records summarization, claim denial prevention, and prior authorization support.